ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.60
0.71%
US Tech 100
19,636.04
0.55%
S&P 500
5,770.20
0.55%
US Dollar vs CAD
1.43715
0.00%
Bitcoin
86,343.75
0.22%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Adaptive Biotechnologies Corporation (ADPT) Share Price

Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation (ADPT)

Adaptogenics Health Corp
7.35
-0.42
(-5.41%)
Closed March 08 3:00PM
Delayed by 15 minutes
7.35
0.00
(0.00%)
After Hours: 6:56PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
7.35
Bid
3.45
Ask
12.64
Volume
2,535,901
7.08 Day's Range 7.92
2.28 52 Week Range 8.94
Market Cap
1.085B
Previous Close
7.77
Open
7.68
Last Trade
6
@
7.13
Last Trade Time
Financial Volume
US$ 18,766,723
VWAP
7.4004
Average Volume (3m)
1,457,680
Shares Outstanding
147,579,486
Dividend Yield
-
PE Ratio
-4.82
Earnings Per Share (EPS)
-1.53
Revenue
170.28M
Net Profit
-225.25M

About Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for... Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.adaptivebiotech.com
Headquarters
Olympia, Washington, USA
Founded
-
Adaptive Biotechnologies Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ADPT. The last closing price for Adaptive Biotechnologies was US$7.77. Over the last year, Adaptive Biotechnologies shares have traded in a share price range of US$ 2.28 to US$ 8.94.

Adaptive Biotechnologies currently has 147,579,486 shares outstanding. The market capitalization of Adaptive Biotechnologies is US$1.15 billion. Adaptive Biotechnologies has a price to earnings ratio (PE ratio) of -4.82.

Ask ADVFN Intelligence (AI)

ADPT Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 06 2025
ADPT (-5.41%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 06 2025
ADPT (-5.41%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 06 2025
ADPT (-5.41%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 06 2025
ADPT (-5.41%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 06 2025
ADPT (-5.41%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 06 2025
ADPT (-5.41%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 06 2025
ADPT (-5.41%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 06 2025
ADPT (-5.41%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 21 2025
ADPT (-5.41%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
February 20 2025
ADPT (-5.41%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.715-8.865468071928.0658.496.96518892538.04607355CS
4-0.68-8.468244084688.038.946.96517429038.13516182CS
121.2320.09803921576.128.945.80514576807.50061642CS
263.0671.32867132874.298.943.98112987926.34197383CS
523.71101.9230769233.648.942.2814091794.79470371CS
156-4.66-38.800999167412.0115.192.2813135306.43112527CS
260-18.11-71.131186174425.4671.252.28115007416.4347573CS

ADPT - Frequently Asked Questions (FAQ)

What is the current Adaptive Biotechnologies share price?
The current share price of Adaptive Biotechnologies is US$ 7.35
How many Adaptive Biotechnologies shares are in issue?
Adaptive Biotechnologies has 147,579,486 shares in issue
What is the market cap of Adaptive Biotechnologies?
The market capitalisation of Adaptive Biotechnologies is USD 1.15B
What is the 1 year trading range for Adaptive Biotechnologies share price?
Adaptive Biotechnologies has traded in the range of US$ 2.28 to US$ 8.94 during the past year
What is the PE ratio of Adaptive Biotechnologies?
The price to earnings ratio of Adaptive Biotechnologies is -4.82
What is the cash to sales ratio of Adaptive Biotechnologies?
The cash to sales ratio of Adaptive Biotechnologies is 6.37
What is the reporting currency for Adaptive Biotechnologies?
Adaptive Biotechnologies reports financial results in USD
What is the latest annual turnover for Adaptive Biotechnologies?
The latest annual turnover of Adaptive Biotechnologies is USD 170.28M
What is the latest annual profit for Adaptive Biotechnologies?
The latest annual profit of Adaptive Biotechnologies is USD -225.25M
What is the registered address of Adaptive Biotechnologies?
The registered address for Adaptive Biotechnologies is 711 CAPITOL WAY S STE 204, UNITED STATES, OLYMPIA, WASHINGTON, 98501 1267
What is the Adaptive Biotechnologies website address?
The website address for Adaptive Biotechnologies is www.adaptivebiotech.com
Which industry sector does Adaptive Biotechnologies operate in?
Adaptive Biotechnologies operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CAPSCapstone Holding Corp
US$ 3.50
(1,300.00%)
36.33k
ABLVAble View Global Inc
US$ 1.73
(137.18%)
5.13M
SUNESUNation Energy Inc
US$ 0.402999
(127.55%)
476.73M
BTOGBit Origin Ltd
US$ 0.6117
(118.46%)
618.03M
DWTXDogwood Therapeutics Inc
US$ 6.63
(49.66%)
25.77M
ALBTAvalon GloboCare Corporation
US$ 6.96
(-36.15%)
570.43k
SCNXScienture Holdings Inc
US$ 1.55
(-35.68%)
1.54M
ACXPAcurx Pharmaceuticals Inc
US$ 0.4572
(-29.88%)
1.13M
RETOReTo Eco Solutions Inc
US$ 5.42
(-27.73%)
108k
OCTOEightco Holdings Inc
US$ 1.08
(-27.03%)
332.1k
BTOGBit Origin Ltd
US$ 0.6117
(118.46%)
622.67M
SUNESUNation Energy Inc
US$ 0.402999
(127.55%)
482.05M
NVDANVIDIA Corporation
US$ 112.69
(1.92%)
341.94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10.675
(-0.70%)
143.04M
ICONIcon Energy Corporation
US$ 0.169898
(17.17%)
142.23M

Discussion

View Full Feed
mick mick 3 minutes ago
hi there and to all,
DTGoody DTGoody 5 minutes ago
I keep saying that I got enough shares, but when you know which way the industry is headed you just got to keep on buying! I saw the .0003's back up on Friday so I just couldn't help myself:

Executed Buy 25,000 AFFU Limit Day 03/07/25 01:24:01 PM EST 25,000 0.0003 4.95
Executed
AFFU
firebag1 firebag1 6 minutes ago
wow thanks for the well thought out and amusing post lmfao...too funny....yup nothing to see here...this post for whatever reason made me change my mind...im selling all my millions of shares Monday am first thing for a 60% loss....i gotta get out asap thanks to this post...thankyou getrichlongtime
HMBL
Craig305 Craig305 8 minutes ago
It is a frustrating wait. Keep in mind they continue to file the quarterly statements on time. They have made a statement they are working on having audited yearly financials for 2022 and 2023.  There has to be a reason for that. 
That proves they are not staying stagnant. They might be movin
AVVH
jimr1717 jimr1717 8 minutes ago
>Newbies< IFUS DD ✅ >>, Marc Walther was found liable in a securities fraud lawsuit...

Complaint:
https://drive.google.com/file/d/1Wpk0lRCJaTOI3dmR_BeSNw6eWtnTt71s/view

Judgement: $397,744.50
https://drive.google.com/file/d/1nZjmmsmCwJlFwm9TR6NvokHH1H3K01u
HGYN IFUS
double_m double_m 8 minutes ago
Too late! Proposals already dropped with 1:20 - 1:100. That would be crazy though. LOL!
MULN
pos_stock_hoarder pos_stock_hoarder 8 minutes ago
Amen to that!
facts_matter14 facts_matter14 9 minutes ago
212 straights weeks of bag holding and down 99% to show for it.

Well deserved team! Well deserved!!!

Can it be?? Absolutely!!!!!!!!







.
SRMX
dmb2 dmb2 10 minutes ago
Oh Please, I just have no time for you, ask your senseless questions to someone else.



GLTA
NWBO
swingingRichard swingingRichard 11 minutes ago
And once again the company claims to have had a great quarter and once again "the market" disagrees. I haven't been through the report. The corrections are imho likely related to the same problem - operating costs. 
GWRE
jimr1717 jimr1717 11 minutes ago
“North” thinkin it’s the wrong “North”
SHMP
facts_matter14 facts_matter14 12 minutes ago
Ironic that a 🗑️ 🤥 next to a post means the post is factual, while a 👍🏻 means it’s total bullshit.

Good thing that people aren’t stupid, as .0001 proves.









.
SRMX
doinit doinit 12 minutes ago
greetings to you. quiet board here. friendly posting warmly received.
PTHRF
$7.00 or Nothing $7.00 or Nothing 15 minutes ago
I know that but the dea gives also quota to api supplier not only to Pharma companies.

In our case, Nasrat hinted in the call that although we got more quota, our api supplier did not (actually because we are his only vyvanse api client). So it is a new situation to deal with. We ne
ELTP
Top Penny Top Penny 15 minutes ago
This does in fact look interesting, but being no bid again, who is to say they won't reverse split like they did last time? You have to admit could very well be the case!
KEGS
crazy horse 0 crazy horse 0 15 minutes ago
FULL Wednesday NIGHT SHOW EU NATO Leaders Have Officially | The Alex Jones Full Show Today

https://www.youtube.com/watch?v=DywCBgjKb4U
Number sleven Number sleven 16 minutes ago
Kiwi, I understand what you are saying. We don't have access to the contracts. This is speculation. PBM's aren't altruistic organizations. If generic companies can't supply for the agreement price, my guess is the contract gets cancelled.
Sleven,
PBM
Hikerbc Hikerbc 16 minutes ago
we need elon here with his chainsaw to reduce corrrupt staff
AMC
Scope08 Scope08 16 minutes ago
I don't think LWLG would announce a "Special Call" out of the blue, just to rehash what has been said before. No, I lean towards us receiving something definitive.
Something good definitive...something bad definitive...something middle of the road definitive...who can tell?
LWLG
Trinityz1 Trinityz1 17 minutes ago
** Be aware **
We ordered a Chinese takeaway from a local place (I won't name them) just been to pick it up and as I was driving home, I heard the bags rustling and moving!!WTF??!!! I thought what the hell is that. Has something got in the bag, I thought I could see a little pair of eyes peer
skitahoe skitahoe 17 minutes ago
In reality, I spent roughly 4 decades in IMGN before a buyout made me a big profit. During those decades I was up and down in the shares I was holding, but never out as I've always believed in the technology. When they sold out, I was somewhere between the highs and lows in the number of shares I
NWBO
DR_rugby DR_rugby 18 minutes ago
Leverage is expanding

And

Cash is decreasing

Now as risk goes up

Small changes cause failures in time

Or the bottom floor prices rises

Based upon ETF cycles I’m looking for

Major moves so
AMC

Your Recent History

NASDAQ
ADPT
Adaptive Biotechnologies
BIT
UI366C
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads